Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
    • Transkriptioner
  • InderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet
Regulatoriskt pressmeddelande

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

Ambu

9.2.2026 08:56:46 CET | Ambu A/S | Changes in company's own shares

On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations.                                                                                            

During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR.

The following transactions have been made under the program from 02 February to 06 February 2026:

 

 

Number of shares

Average purchase price, DKK

Transaction value, DKK

Accumulated under the program after last announcement

1,475,270

86.2430

127,231,753

2026.02.02

116,000

84.6254

 9,816,546

2026.02.03

70,000

84.0157

 5,881,099

2026.02.04

0

0.0000

 -  

2026.02.05

12,714

84.1270

 1,069,591

2026.02.06

0

0.0000

 -  

Accumulated under the program

1,673,984

86.0217

143,998,989

After the above mentioned transactions DKK 6,001,011 remains to be repurchased. Ambu now owns 4,123,108 treasury shares, corresponding to 1.5% of the share capital.

Contacts

  • Anders Hjort, Head of Investor Relations, +45 2892 8881, anhj@ambu.com
  • Tine Bjørn Schmidt, Director of Corporate Communications, +45 2264 0697, tisc@ambu.com

About Ambu A/S

Ever since 1937, Ambu has surpassed expectations with groundbreaking solutions that improve patient care. Millions of patients, clinicians, and health systems worldwide rely on our endoscopy, anesthesia, and patient monitoring solutions for efficiency, safety, and performance. Our ownership of every stage of the product life cycle enables us to work closely with healthcare professionals, maintain a reliable product supply, and uphold full transparency. At our headquarters in Copenhagen, Denmark, and around the world in Europe, North America, and the Asia Pacific, 5,200+ Ambu team members are committed to delivering above and beyond.

Attachments

  • Download announcement as PDF.pdf
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.